Dr. Lui Franciosi reports
VERITAS PHARMA INC CLOSES ON ITS ACQUISITION OF CANNEVERT THERAPEUTICS LTD
Veritas Pharma Inc., further to its Dec. 21, 2015, and Oct. 5, 2016, news releases, has paid the final instalment for its acquisition of 80 per cent of the issued and outstanding shares in Cannevert Therapeutics Ltd., and the company will enter into a second amending agreement with respect to the existing share purchase agreement with Cannevert.
Pursuant to the second amending agreement, the company and Cannevert will engage an independent business valuator within 90 days to report on the value of Cannevert. The company will provide a future update once a valuator has been appointed.
About Veritas Pharma Inc.
Veritas Pharma is an emerging-stage pharmaceutical and intellectual property development company, which, through Cannevert Therapeutics Ltd., is advancing the science behind medical cannabis.
We seek Safe Harbor.
© 2017 Canjex Publishing Ltd. All rights reserved.